- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07919522
The Prospective Observational Study Evaluating the Clinical Profile and Correlation of Subjective and Objective Parameters of GERD in a Tertiary Care Hospital : An Indian Perspective
This prospective, single-center study at AIG Hospitals, Hyderabad, aims to establish normal 24-hour ambulatory esophageal pH-impedance values, including acid exposure time (AET), in 50 healthy Indian adults. Current Western diagnostic cut-offs may not be applicable to the Indian population, where normal AET is likely lower. Healthy volunteers aged 18-50 with no GI symptoms or systemic diseases will undergo baseline evaluations, high-resolution manometry, and 24-hour pH-impedance monitoring while maintaining regular activities. The study will assess how diet, body position, and sleep affect reflux, with statistical analysis to determine normative values for improved GERD diagnosis in India.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Telangana
-
Hyderabad, Telangana, India, 500032
- AIG hospitals
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
This study will include adults aged 18-50 years with GERD symptoms
Description
Inclusion Criteria:
Age ≥18 years.
Symptoms of GERD (heartburn, regurgitation, chest pain) diagnosed using:
Clinical symptoms based on validated questionnaires. Endoscopic findings (e.g., esophagitis, Barrett's esophagus). Provide written informed consent.
Exclusion Criteria:
Pregnant women or breast-feeding women
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
|---|
|
This study will include a cohort of adults aged 18-50 years with GERD symptoms
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To correlate the subjective (GERD HRQL scores) and objective (Endoscopy, Esophageal manometry and 24-hour pH- impedance monitoring) parameters of GERD
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To develop predective models for forecasting manometric and pH findings
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GERDCR-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.